AG

Artal Group Portfolio holdings

AUM $930M
1-Year Est. Return 3.57%
This Quarter Est. Return
1 Year Est. Return
-3.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.12B
AUM Growth
+$1.44B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
139
New
Increased
Reduced
Closed

Top Buys

1
+$1.31B
2
+$63.6M
3
+$38.1M
4
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$20.4M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$18.7M

Top Sells

1
+$61.1M
2
+$15.8M
3
+$15.1M
4
FATE icon
Fate Therapeutics
FATE
+$14.8M
5
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$13.1M

Sector Composition

1 Healthcare 56.49%
2 Consumer Discretionary 42.78%
3 Technology 0.24%
4 Financials 0.2%
5 Real Estate 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
$434K 0.01%
1,606,309
102
$406K 0.01%
200,000
103
$397K 0.01%
24,000
104
$379K 0.01%
125,000
105
$350K 0.01%
10,975
106
$307K 0.01%
+25,000
107
$293K 0.01%
+4,500
108
$261K 0.01%
10,000
+5,000
109
$194K 0.01%
5,440
-20,733
110
$178K 0.01%
+936
111
$80K ﹤0.01%
31,055
112
$35K ﹤0.01%
5,556
113
$27K ﹤0.01%
1,490
-253,595
114
– –
-4,000
115
– –
-1,018,303
116
– –
-18,108
117
– –
-8,000
118
– –
-500,000
119
– –
-67,909
120
– –
-500,000
121
– –
-2,600,000
122
– –
-75,000
123
– –
-1,274,713
124
– –
-400,000
125
– –
-2,746
2 3 4
5
6